Press Releases
-
Jun 13, 2018Company Acquires FDA-Approved, Commercial-Stage Product to Complement Natesto® Sales Efforts Among Primary Care Physicians...May 23, 2018ENGLEWOOD, CO / ACCESSWIRE / May 23, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced today that it will be presenting at the 8th Annual LD Micro Invitational investor conference on Tuesday, June 5th, at 9:00 AM PST / 11:00 AM EST at the Luxe Sunset Boulevard Hotel in Los Angeles,...May 14, 2018ENGLEWOOD, CO / ACCESSWIRE / May 14, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including the company's operational and financial results for its fiscal third quarter ended March 31, 2018. The company will host a live conference call and web...May 8, 2018ENGLEWOOD, CO / ACCESSWIRE / May 8, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has highlighted its progress of the company's commercial strategy in the below letter to shareholders....May 7, 2018ENGLEWOOD, CO / ACCESSWIRE / May 7, 2018 / Aytu BioScience, Inc. (AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the company will present its operational results for the fiscal third quarter 2018 on Monday, May 14, 2018, at 4:30 p.m. ET. The company will review recent accomplishments and provide an overvi...May 3, 2018ENGLEWOOD, CO / ACCESSWIRE / May 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company"), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has been featured in a local ABC News segment presented by medical specialist anchor Kristi Krueger: "UM doctors test new medication for treating men with low testosterone. Nasal testosteron...Apr 3, 2018ENGLEWOOD, CO / ACCESSWIRE / April 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company") will be presenting at this year's MicroCap Conference on Tuesday, April 10, 2018 at 10:30 am....Mar 20, 2018Post-hoc Data Analysis Demonstrates Natesto's Restoration of Normal Testosterone Levels in Hypogonadal Men While Maintaining Normal Levels of Estradiol (E2) and Dihydrotestosterone (DHT), Which Are Frequently Altered in Men Treated With Testosterone Replacement Therapy...Mar 7, 2018ENGLEWOOD, Colo., March 7, 2018 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that it has received registration in Mexico for the MiOXSYS System, from the Secretary of Health at Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). The M...Mar 6, 2018ENGLEWOOD, Colo., March 6, 2018 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company"), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the closing of its previously announced underwritten public offering for total gross proceeds of $12,000,000, before deducting underwriting discounts, commissions and o...